Post-Stroke Aphasia TMS
Part of paid clinical trials in Milwaukee, Wisconsin.
- Sponsor
- Medical College of Wisconsin
- Study ID
- NCT06974279
- Status
- Recruiting
Conditions
- Aphasia
- Language
- Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Precision TMS with SFA — DEVICEExcitatory TMS delivered using a precision site finding approach and intermittent theta burst stimulation protocol
- Control TMS with SFA — DEVICEExcitatory TMS using intermittent theta burst stimulation delivered to a control vertex site.
Study Details
The investigator proposes to examine the effects of excitatory transcranial magnetic stimulation (TMS) combined with semantic feature analysis (SFA) language therapy to improve word-finding abilities in stroke survivors with aphasia (SWA).
Key Dates
- Start date
- Sep 1, 2025
- Status verified
- Sep 2025
- Primary completion
- Dec 31, 2036
- Completion
- Dec 31, 2036
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Precision TMSSFA will be administered immediately after precision TMS
- Placebo Comparator: Control TMSSFA will be administered immediately after control TMS
Primary Outcome Measure
Accuracy on a picture naming test [ Time Frame: immediately after and 8-12 weeks after last SFA+TMS treatment ]
Central Contacts
- Sidney Schoenrock, MA414-955-7579
- Ari Hjelmeseth414-955-7578
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Priyanka Shah-Basak, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Milwaukee, WI
By condition
By specialty
By research site
Related Studies
- A Closed Loop Neural Activity Triggered Stroke Rehabilitation DeviceRecruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Use of Sensory Substitution to Improve Arm Control After StrokeRecruiting · Marquette University · Milwaukee, Wisconsin
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas